View Document Preview and Link Document Date: 2014-10-14 09:30:58 Open Document File Size: 80,30 KB Share Result on Facebook
Company Organon Laboratories Limited / Aspen Pharma Trading Limited / / Country United Kingdom / Northern Ireland / Scotland / Sweden / Wales / / / Event Product Issues / / IndustryTerm healthcare professionals / mg/ml solution / manufacturing process / / MedicalCondition focal segmental glomerulosclerosis / potential cardiac disorders / remitting relapsing multiple sclerosis / severe allergic reactions / proteinuria / minimal change disease / onset hypertension / membranoproliferative glomerulonephritis / thrombotic thrombocytopenic purpura / joint inflammation / thrombocytopenia / thrombocytopenia / new onset hypertension / fever / nephrotic syndrome / renal disease / cardiac arrest / occlusive microvascular thrombosis / paresis / haemolytic uraemic syndrome / membranous glomerulopathy / Nephrotic syndrome Nephrotic syndrome / severe asthma / kidney disorder / atrial flutter / collapsing focal segmental glomerulosclerosis / / MedicalTreatment plasma exchange / renal transplantation / / Organization MHRA / Commission on Human Medicines / Department for Transport / Commission on Human Medicines Volume / European Union / NHS / Medicines and Healthcare products Regulatory Agency / / Position Editor / Governor / independent advisor / / Product Simulect / Dexamethasone / dexamethasone sodium phosphate / Rebif / renal function / / Region Northern Ireland / / Technology transplantation / pdf / / URL http / SocialTag 
Latest advice for medicines users The monthly newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines Volume 8, Issue 3, October[removed]Content